404 related articles for article (PubMed ID: 2404210)
41. Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.
Matsumura K; Nonaka I; Tomé FM; Arahata K; Collin H; Leturcq F; Récan D; Kaplan JC; Fardeau M; Campbell KP
Am J Hum Genet; 1993 Aug; 53(2):409-16. PubMed ID: 8328458
[TBL] [Abstract][Full Text] [Related]
42. A screening for dystrophin gene deletions in Japanese patients with Duchenne/Becker muscular dystrophy by the multiplex polymerase chain reaction.
Sakuraba H; Ishii K; Shimmoto M; Yamada H; Suzuki Y
Brain Dev; 1991 Sep; 13(5):339-42. PubMed ID: 1785656
[TBL] [Abstract][Full Text] [Related]
43. [Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].
Takeshima Y; Matsuo M
Nihon Rinsho; 1997 Dec; 55(12):3120-5. PubMed ID: 9436421
[TBL] [Abstract][Full Text] [Related]
44. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
Uchino M; Miike T; Iwashita H; Uyama E; Yoshioka K; Sugino S; Ando M
J Neurol Sci; 1994 Jul; 124(2):225-9. PubMed ID: 7964876
[TBL] [Abstract][Full Text] [Related]
45. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
[TBL] [Abstract][Full Text] [Related]
46. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.
Darras BT; Koenig M; Kunkel LM; Francke U
Am J Med Genet; 1988 Mar; 29(3):713-26. PubMed ID: 2897793
[TBL] [Abstract][Full Text] [Related]
47. [Central nervous system involvements in Duchenne/Becker muscular dystrophy].
Kumagai T; Miura K; Ohki T; Matsumoto A; Miyazaki S; Nakamura M; Ochi N; Takahashi O
No To Hattatsu; 2001 Nov; 33(6):480-6. PubMed ID: 11725514
[TBL] [Abstract][Full Text] [Related]
48. Duchenne and Becker muscular dystrophy mutations: analysis using 2.6 kb of muscle cDNA from the 5' end of the gene.
Smith TJ; Forrest SM; Cross GS; Davies KE
Nucleic Acids Res; 1987 Dec; 15(23):9761-9. PubMed ID: 3697082
[TBL] [Abstract][Full Text] [Related]
49. Brother/sister pairs affected with early-onset, progressive muscular dystrophy: molecular studies reveal etiologic heterogeneity.
Francke U; Darras BT; Hersh JH; Berg BO; Miller RG
Am J Hum Genet; 1989 Jul; 45(1):63-72. PubMed ID: 2568091
[TBL] [Abstract][Full Text] [Related]
50. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
51. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy.
Hodgson S; Hart K; Abbs S; Heckmatt J; Rodillo E; Bobrow M; Dubowitz V
J Med Genet; 1989 Nov; 26(11):682-93. PubMed ID: 2585468
[TBL] [Abstract][Full Text] [Related]
52. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
Winnard AV; Mendell JR; Prior TW; Florence J; Burghes AH
Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572
[TBL] [Abstract][Full Text] [Related]
53. Molecular deletion patterns in Turkish Duchenne and Becker muscular dystrophy patients.
Dinçer P; Topaloğlu H; Ayter S; Ozgüç M; Taşdemir HA; Renda Y
Brain Dev; 1996; 18(2):91-4. PubMed ID: 8733896
[TBL] [Abstract][Full Text] [Related]
54. [Deletions within the gene of dystrophin in Duchenne and Becker muscular dystrophy].
Zimowski JG; Bisko M; Fidziańska E; Hausmanowa-Petrusewicz I; Badurska B; Borkowska J; Lusakowska A; Fidziańska A; Jezuita J; Zaremba J
Neurol Neurochir Pol; 1993; 27(4):469-78. PubMed ID: 8247234
[TBL] [Abstract][Full Text] [Related]
55. Molecular genetic and immunological analysis of dystrophin of a young patient with X-linked muscular dystrophy.
Ikeya K; Saito K; Hayashi K; Tanaka H; Hagiwara Y; Yoshida M; Yamauchi A; Fukuyama Y; Ishiguro T; Eguchi C
Am J Med Genet; 1992 Jun; 43(3):580-7. PubMed ID: 1605252
[TBL] [Abstract][Full Text] [Related]
56. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.
Towbin JA; Hejtmancik JF; Brink P; Gelb B; Zhu XM; Chamberlain JS; McCabe ER; Swift M
Circulation; 1993 Jun; 87(6):1854-65. PubMed ID: 8504498
[TBL] [Abstract][Full Text] [Related]
57. Deletions in the 5' region of dystrophin and resulting phenotypes.
Muntoni F; Gobbi P; Sewry C; Sherratt T; Taylor J; Sandhu SK; Abbs S; Roberts R; Hodgson SV; Bobrow M
J Med Genet; 1994 Nov; 31(11):843-7. PubMed ID: 7853367
[TBL] [Abstract][Full Text] [Related]
58. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy.
Bushby KM; Goodship JA; Nicholson LV; Johnson MA; Haggerty ID; Gardner-Medwin D
Neuromuscul Disord; 1993 Jan; 3(1):57-64. PubMed ID: 8329890
[TBL] [Abstract][Full Text] [Related]
59. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.
Bulman DE; Murphy EG; Zubrzycka-Gaarn EE; Worton RG; Ray PN
Am J Hum Genet; 1991 Feb; 48(2):295-304. PubMed ID: 1990838
[TBL] [Abstract][Full Text] [Related]
60. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.
Ehrenpreis J; Hillers M; Junkes B; Pfordt M; Schwinger E; Vosberg HP
Genomics; 1991 Jul; 10(3):551-7. PubMed ID: 1889805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
